Showcasing the Antigen-Specific CNP Nanoparticle Treatment Regulates CD8+ T Cells in a Model of Type 1 Diabetes
Time: 11:00 am
day: Custom Day Two
Details:
• Developing nanoparticles that bind to monocytes and enhance uptake
• Ensuring optimal, targeted delivery of ASIT therapies through nanoparticles
• Harnessing COUR’s nanoparticle technology to reprogram the immune system for a breakthrough approach to treating autoimmune disease
